These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
137 related articles for article (PubMed ID: 34010183)
1. Impact of renin-angiotensin system inhibitors after revascularization of patients with left main coronary artery disease. Chen S; Redfors B; Serruys PW; Pieter Kappetein A; Crowley A; Ben-Yehuda O; Srdanovic I; Lembo NJ; Brown WM; Sabik JF; Stone GW Coron Artery Dis; 2022 Jan; 31(1):37-44. PubMed ID: 34010183 [TBL] [Abstract][Full Text] [Related]
2. Left Main Coronary Artery Disease Revascularization According to the SYNTAX Score. Shlofmitz E; Généreux P; Chen S; Dressler O; Ben-Yehuda O; Morice MC; Puskas JD; Taggart DP; Kandzari DE; Crowley A; Redfors B; Mehdipoor G; Kappetein AP; Sabik JF; Serruys PW; Stone GW Circ Cardiovasc Interv; 2019 Sep; 12(9):e008007. PubMed ID: 31495220 [TBL] [Abstract][Full Text] [Related]
3. Outcomes of patients with and without baseline lipid-lowering therapy undergoing revascularization for left main coronary artery disease: analysis from the EXCEL trial. Chen S; Redfors B; Liu Y; Vrolix M; Macaya C; Ben-Yehuda O; Kappetein AP; Sabik JF; Serruys PW; Stone GW Coron Artery Dis; 2019 Mar; 30(2):143-149. PubMed ID: 30531253 [TBL] [Abstract][Full Text] [Related]
4. Left Main Percutaneous Coronary Intervention Versus Coronary Artery Bypass Grafting in Patients With Prior Cerebrovascular Disease: Results From the EXCEL Trial. Diamond J; Madhavan MV; Sabik JF; Serruys PW; Kappetein AP; Leon MB; Taggart DP; Berland J; Morice MC; Gersh BJ; Kandzari DE; Dressler O; Stone GW JACC Cardiovasc Interv; 2018 Dec; 11(24):2441-2450. PubMed ID: 30573053 [TBL] [Abstract][Full Text] [Related]
5. Bypass Surgery or Stenting for Left Main Coronary Artery Disease in Patients With Diabetes. Milojevic M; Serruys PW; Sabik JF; Kandzari DE; Schampaert E; van Boven AJ; Horkay F; Ungi I; Mansour S; Banning AP; Taggart DP; Sabaté M; Gershlick AH; Bochenek A; Pomar J; Lembo NJ; Noiseux N; Puskas JD; Crowley A; Kosmidou I; Mehran R; Ben-Yehuda O; Généreux P; Pocock SJ; Simonton CA; Stone GW; Kappetein AP J Am Coll Cardiol; 2019 Apr; 73(13):1616-1628. PubMed ID: 30947913 [TBL] [Abstract][Full Text] [Related]
6. Outcomes After Left Main Coronary Artery Revascularization by Percutaneous Coronary Intervention or Coronary Artery Bypass Grafting According to Smoking Status. Shahim B; Redfors B; Chen S; Morice MC; Gersh BJ; Puskas JD; Kandzari DE; Merkely B; Horkay F; Crowley A; Serruys PW; Kappetein AP; Sabik JF; Ben-Yehuda O; Stone GW Am J Cardiol; 2020 Jul; 127():16-24. PubMed ID: 32360038 [TBL] [Abstract][Full Text] [Related]
7. Usefulness of Discharge Resting Heart Rate to Predict Adverse Cardiovascular Outcomes in Patients With Left Main Coronary Artery Disease Revascularized With Percutaneous Coronary Intervention vs Coronary Artery Bypass Grafting (from the EXCEL Trial). Kosmidou I; Crowley A; Macedo L; Ben-Yehuda O; Gersh BJ; Boonstra PW; Kappetein AP; Serruys PW; Sabik JF; Stone GW Am J Cardiol; 2020 Jan; 125(2):169-175. PubMed ID: 31735328 [TBL] [Abstract][Full Text] [Related]
8. Left Main Revascularization With PCI or CABG in Patients With Chronic Kidney Disease: EXCEL Trial. Giustino G; Mehran R; Serruys PW; Sabik JF; Milojevic M; Simonton CA; Puskas JD; Kandzari DE; Morice MC; Taggart DP; Gershlick AH; Généreux P; Zhang Z; McAndrew T; Redfors B; Ragosta M; Kron IL; Dressler O; Leon MB; Pocock SJ; Ben-Yehuda O; Kappetein AP; Stone GW J Am Coll Cardiol; 2018 Aug; 72(7):754-765. PubMed ID: 30092952 [TBL] [Abstract][Full Text] [Related]
9. New-Onset Atrial Fibrillation After PCI or CABG for Left Main Disease: The EXCEL Trial. Kosmidou I; Chen S; Kappetein AP; Serruys PW; Gersh BJ; Puskas JD; Kandzari DE; Taggart DP; Morice MC; Buszman PE; Bochenek A; Schampaert E; Pagé P; Sabik JF; McAndrew T; Redfors B; Ben-Yehuda O; Stone GW J Am Coll Cardiol; 2018 Feb; 71(7):739-748. PubMed ID: 29447735 [TBL] [Abstract][Full Text] [Related]
10. B-Type Natriuretic Peptide Assessment in Patients Undergoing Revascularization for Left Main Coronary Artery Disease: Analysis From the EXCEL Trial. Redfors B; Chen S; Crowley A; Ben-Yehuda O; Gersh BJ; Lembo NJ; Brown WM; Banning AP; Taggart DP; Serruys PW; Kappetein AP; Sabik JF; Stone GW Circulation; 2018 Jul; 138(5):469-478. PubMed ID: 29666071 [TBL] [Abstract][Full Text] [Related]
11. Stroke Rates Following Surgical Versus Percutaneous Coronary Revascularization. Head SJ; Milojevic M; Daemen J; Ahn JM; Boersma E; Christiansen EH; Domanski MJ; Farkouh ME; Flather M; Fuster V; Hlatky MA; Holm NR; Hueb WA; Kamalesh M; Kim YH; Mäkikallio T; Mohr FW; Papageorgiou G; Park SJ; Rodriguez AE; Sabik JF; Stables RH; Stone GW; Serruys PW; Kappetein AP J Am Coll Cardiol; 2018 Jul; 72(4):386-398. PubMed ID: 30025574 [TBL] [Abstract][Full Text] [Related]
12. Mortality After Repeat Revascularization Following PCI or CABG for Left Main Disease: The EXCEL Trial. Giustino G; Serruys PW; Sabik JF; Mehran R; Maehara A; Puskas JD; Simonton CA; Lembo NJ; Kandzari DE; Morice MC; Taggart DP; Gershlick AH; Ragosta M; Kron IL; Liu Y; Zhang Z; McAndrew T; Dressler O; Généreux P; Ben-Yehuda O; Pocock SJ; Kappetein AP; Stone GW JACC Cardiovasc Interv; 2020 Feb; 13(3):375-387. PubMed ID: 31954680 [TBL] [Abstract][Full Text] [Related]
13. Quality-of-Life After Everolimus-Eluting Stents or Bypass Surgery for Left-Main Disease: Results From the EXCEL Trial. Baron SJ; Chinnakondepalli K; Magnuson EA; Kandzari DE; Puskas JD; Ben-Yehuda O; van Es GA; Taggart DP; Morice MC; Lembo NJ; Brown WM; Banning A; Simonton CA; Kappetein AP; Sabik JF; Serruys PW; Stone GW; Cohen DJ; J Am Coll Cardiol; 2017 Dec; 70(25):3113-3122. PubMed ID: 29097293 [TBL] [Abstract][Full Text] [Related]
14. Impact of renin-angiotensin system blockade on the prognosis of acute coronary syndrome based on left ventricular ejection fraction. Raposeiras-Roubín S; Abu-Assi E; Cespón-Fernández M; Ibáñez B; García-Ruiz JM; D'Ascenzo F; Simao Henriques JP; Saucedo J; Caneiro-Queija B; Cobas-Paz R; Muñoz-Pousa I; Wilton SB; González Juanatey JR; Kikkert WJ; Núñez-Gil I; Ariza-Solé A; Song X; Alexopoulos D; Liebetrau C; Kawaji T; Gaita F; Huczek Z; Nie SP; Yan Y; Fujii T; Correia L; Kawashiri MA; Kedev S; Southern D; Alfonso E; Terol B; Garay A; Zhang D; Chen Y; Xanthopoulou I; Osman N; Möllmann H; Shiomi H; Giordana F; Kowara M; Filipiak K; Wang X; Fan JY; Ikari Y; Nakahayshi T; Sakata K; Yamagishi M; Kalpak O; Íñiguez-Romo A Rev Esp Cardiol (Engl Ed); 2020 Feb; 73(2):114-122. PubMed ID: 31105064 [TBL] [Abstract][Full Text] [Related]
15. Long-term forecasting and comparison of mortality in the Evaluation of the Xience Everolimus Eluting Stent vs. Coronary Artery Bypass Surgery for Effectiveness of Left Main Revascularization (EXCEL) trial: prospective validation of the SYNTAX Score II. Campos CM; van Klaveren D; Farooq V; Simonton CA; Kappetein AP; Sabik JF; Steyerberg EW; Stone GW; Serruys PW; Eur Heart J; 2015 May; 36(20):1231-41. PubMed ID: 25583761 [TBL] [Abstract][Full Text] [Related]
16. Outcomes After Coronary Stenting or Bypass Surgery for Men and Women With Unprotected Left Main Disease: The EXCEL Trial. Serruys PW; Cavalcante R; Collet C; Kappetein AP; Sabik JF; Banning AP; Taggart DP; Sabaté M; Pomar J; Boonstra PW; Lembo NJ; Onuma Y; Simonton CA; Morice MC; McAndrew T; Dressler O; Stone GW JACC Cardiovasc Interv; 2018 Jul; 11(13):1234-1243. PubMed ID: 29976359 [TBL] [Abstract][Full Text] [Related]
17. Everolimus-Eluting Stents or Bypass Surgery for Left Main Coronary Artery Disease. Stone GW; Sabik JF; Serruys PW; Simonton CA; Généreux P; Puskas J; Kandzari DE; Morice MC; Lembo N; Brown WM; Taggart DP; Banning A; Merkely B; Horkay F; Boonstra PW; van Boven AJ; Ungi I; Bogáts G; Mansour S; Noiseux N; Sabaté M; Pomar J; Hickey M; Gershlick A; Buszman P; Bochenek A; Schampaert E; Pagé P; Dressler O; Kosmidou I; Mehran R; Pocock SJ; Kappetein AP; N Engl J Med; 2016 Dec; 375(23):2223-2235. PubMed ID: 27797291 [TBL] [Abstract][Full Text] [Related]
18. Impact of chronic obstructive pulmonary disease on prognosis after percutaneous coronary intervention and bypass surgery for left main coronary artery disease: an analysis from the EXCEL trial. Huang X; Redfors B; Chen S; Liu Y; Ben-Yehuda O; Puskas JD; Kandzari DE; Merkely B; Horkay F; van Boven AJ; Boonstra PW; Sabik JF; Serruys PW; Kappetein AP; Stone GW Eur J Cardiothorac Surg; 2019 Jun; 55(6):1144-1151. PubMed ID: 30596978 [TBL] [Abstract][Full Text] [Related]
19. Outcomes After Left Main Percutaneous Coronary Intervention Versus Coronary Artery Bypass Grafting According to Lesion Site: Results From the EXCEL Trial. Gershlick AH; Kandzari DE; Banning A; Taggart DP; Morice MC; Lembo NJ; Brown WM; Banning AP; Merkely B; Horkay F; van Boven AJ; Boonstra PW; Dressler O; Sabik JF; Serruys PW; Kappetein AP; Stone GW JACC Cardiovasc Interv; 2018 Jul; 11(13):1224-1233. PubMed ID: 29976358 [TBL] [Abstract][Full Text] [Related]
20. Prognostic Effect of the SYNTAX Score on 10-Year Outcomes After Left Main Coronary Artery Revascularization in a Randomized Population: Insights From the Extended PRECOMBAT Trial. Lee J; Ahn JM; Kim JH; Jeong YJ; Hyun J; Yang Y; Lee JS; Park H; Kang DY; Lee PH; Park DW; Park SJ; J Am Heart Assoc; 2021 Jul; 10(14):e020359. PubMed ID: 34227392 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]